X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19128) 19128
Publication (1187) 1187
Book Chapter (81) 81
Book Review (63) 63
Conference Proceeding (40) 40
Dissertation (28) 28
Magazine Article (23) 23
Book / eBook (9) 9
Newspaper Article (5) 5
Data Set (4) 4
Web Resource (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6648) 6648
pyrazine derivatives (4891) 4891
index medicus (4773) 4773
pyrazines - pharmacology (4520) 4520
animals (4062) 4062
male (3917) 3917
bortezomib (3908) 3908
pyrazines - therapeutic use (2956) 2956
female (2894) 2894
middle aged (2021) 2021
pyrazines - administration & dosage (1984) 1984
pyrazine (1832) 1832
oncology (1767) 1767
pyrazines (1712) 1712
aged (1554) 1554
boronic acids - therapeutic use (1532) 1532
adult (1519) 1519
rats (1516) 1516
boronic acids - pharmacology (1481) 1481
multiple myeloma - drug therapy (1476) 1476
mice (1442) 1442
pyrazines - chemistry (1357) 1357
boronic acids - administration & dosage (1236) 1236
pharmacology & pharmacy (1188) 1188
ring closure reactions (1183) 1183
hematology (1166) 1166
cell line, tumor (1071) 1071
pyrazines - adverse effects (1067) 1067
antineoplastic agents - therapeutic use (1003) 1003
antineoplastic agents - pharmacology (994) 994
treatment outcome (994) 994
apoptosis (975) 975
multiple myeloma (926) 926
chemistry, organic (920) 920
apoptosis - drug effects (905) 905
cancer (895) 895
antineoplastic combined chemotherapy protocols - therapeutic use (878) 878
analysis (853) 853
dose-response relationship, drug (831) 831
biochemistry & molecular biology (814) 814
chemistry, multidisciplinary (812) 812
sitagliptin phosphate (778) 778
proteasome inhibitors (713) 713
chemistry (708) 708
pyrazines - chemical synthesis (703) 703
chemistry, medicinal (699) 699
chemistry, inorganic & nuclear (687) 687
research (683) 683
boronic acids - adverse effects (675) 675
derivatives (642) 642
pharmacology, medicinal chemistry, vaccines, serums (567) 567
molecular structure (561) 561
therapy (558) 558
structure-activity relationship (555) 555
rats, sprague-dawley (554) 554
diabetes mellitus, type 2 - drug therapy (541) 541
expression (540) 540
multiple-myeloma (538) 538
chemistry, physical (521) 521
time factors (521) 521
care and treatment (517) 517
article (508) 508
ligands (507) 507
drug therapy, combination (469) 469
protease inhibitors - pharmacology (467) 467
pyrazines - metabolism (463) 463
activation (460) 460
chemotherapy (458) 458
triazoles - therapeutic use (458) 458
multiple myeloma - pathology (456) 456
aged, 80 and over (455) 455
cell proliferation - drug effects (455) 455
heterocyclic compounds (450) 450
protease inhibitors - therapeutic use (447) 447
dexamethasone - administration & dosage (441) 441
endocrinology & metabolism (432) 432
drug synergism (421) 421
nf-kappa-b (411) 411
in vitro techniques (406) 406
thalidomide - analogs & derivatives (406) 406
pyrazines - pharmacokinetics (404) 404
antineoplastic agents - adverse effects (400) 400
cells (400) 400
pyridine (398) 398
complexes (394) 394
food science & technology (386) 386
dexamethasone (374) 374
clinical trials as topic (372) 372
proteins (369) 369
drug therapy (367) 367
hypoglycemic agents - therapeutic use (362) 362
cell biology (359) 359
proteasome endopeptidase complex - metabolism (359) 359
antineoplastic agents - administration & dosage (352) 352
thalidomide - administration & dosage (347) 347
kinetics (338) 338
models, molecular (337) 337
pyridine derivatives (334) 334
cells, cultured (332) 332
abridged index medicus (330) 330
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17997) 17997
Chinese (505) 505
Japanese (175) 175
German (166) 166
French (156) 156
Russian (60) 60
Polish (48) 48
Spanish (47) 47
Italian (37) 37
Czech (27) 27
Hungarian (15) 15
Portuguese (10) 10
Danish (7) 7
Swedish (7) 7
Slovak (5) 5
Dutch (4) 4
Korean (4) 4
Norwegian (4) 4
Hebrew (3) 3
Finnish (2) 2
Turkish (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2002, The chemistry of heterocyclic compounds, ISBN 0471403822, Volume 58
Web Resource
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2009, Volume 17, Issue 6, pp. 2607 - 2622
Journal Article
Tetrahedron Letters, ISSN 0040-4039, 09/2019, Volume 60, Issue 39, p. 151089
The regioselective cyclocondensation of aminoethyl-1,2,4-triazoles and glyoxal provides pentacyclic heterocycles in which two 7,8-dihydro-5 -6λ... 
1,2,4-Triazole | Conformationally rigid | Cyclization | Pyrazine
Journal Article
Toxicological Sciences, ISSN 1096-6080, 10/2003, Volume 75, Issue 2, pp. 393 - 401
Sidestream cigarette smoke solution was previously screened to identify the groups of chemicals in smoke that inhibit growth and angiogenesis in the chick... 
pyrazine
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
TRIAL | PLUS DEXAMETHASONE | ABNORMALITIES | HIGH-DOSE THERAPY | COMPLETE RESPONSE | DOXORUBICIN | PERIPHERAL NEUROPATHY | CONTINUED STANDARD CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | DELETION | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 03/2015, Volume 93, pp. 330 - 337
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2006, Volume 91, Issue 11, pp. 4612 - 4619
Journal Article